1. Home
  2. AVTR vs BBIO Comparison

AVTR vs BBIO Comparison

Compare AVTR & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTR
  • BBIO
  • Stock Information
  • Founded
  • AVTR 1904
  • BBIO 2015
  • Country
  • AVTR United States
  • BBIO United States
  • Employees
  • AVTR N/A
  • BBIO N/A
  • Industry
  • AVTR Biotechnology: Laboratory Analytical Instruments
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVTR Industrials
  • BBIO Health Care
  • Exchange
  • AVTR Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • AVTR 9.4B
  • BBIO 8.8B
  • IPO Year
  • AVTR 2019
  • BBIO 2019
  • Fundamental
  • Price
  • AVTR $13.27
  • BBIO $49.08
  • Analyst Decision
  • AVTR Buy
  • BBIO Strong Buy
  • Analyst Count
  • AVTR 13
  • BBIO 16
  • Target Price
  • AVTR $16.54
  • BBIO $61.69
  • AVG Volume (30 Days)
  • AVTR 14.3M
  • BBIO 2.9M
  • Earning Date
  • AVTR 08-01-2025
  • BBIO 08-05-2025
  • Dividend Yield
  • AVTR N/A
  • BBIO N/A
  • EPS Growth
  • AVTR 94.25
  • BBIO N/A
  • EPS
  • AVTR 1.01
  • BBIO N/A
  • Revenue
  • AVTR $6,665,800,000.00
  • BBIO $235,812,000.00
  • Revenue This Year
  • AVTR $0.49
  • BBIO $106.33
  • Revenue Next Year
  • AVTR $3.29
  • BBIO $54.30
  • P/E Ratio
  • AVTR $13.14
  • BBIO N/A
  • Revenue Growth
  • AVTR N/A
  • BBIO 7.62
  • 52 Week Low
  • AVTR $10.83
  • BBIO $21.72
  • 52 Week High
  • AVTR $27.83
  • BBIO $51.86
  • Technical
  • Relative Strength Index (RSI)
  • AVTR 55.24
  • BBIO 55.76
  • Support Level
  • AVTR $12.48
  • BBIO $48.03
  • Resistance Level
  • AVTR $13.09
  • BBIO $51.86
  • Average True Range (ATR)
  • AVTR 0.45
  • BBIO 1.95
  • MACD
  • AVTR 0.12
  • BBIO -0.08
  • Stochastic Oscillator
  • AVTR 98.68
  • BBIO 71.55

About AVTR Avantor Inc.

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: